Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 4
2006 7
2007 7
2008 4
2009 6
2010 4
2011 10
2012 4
2013 15
2014 28
2015 31
2016 22
2017 11
2018 16
2019 18
2020 28
2021 26
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

228 results
Results by year
Filters applied: . Clear all
Page 1
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng AL. Kudo M, et al. Among authors: ren m. Lancet. 2018 Mar 24;391(10126):1163-1173. doi: 10.1016/S0140-6736(18)30207-1. Lancet. 2018. PMID: 29433850 Free article. Clinical Trial.
An engineered IL-2 partial agonist promotes CD8+ T cell stemness.
Mo F, Yu Z, Li P, Oh J, Spolski R, Zhao L, Glassman CR, Yamamoto TN, Chen Y, Golebiowski FM, Hermans D, Majri-Morrison S, Picton LK, Liao W, Ren M, Zhuang X, Mitra S, Lin JX, Gattinoni L, Powell JD, Restifo NP, Garcia KC, Leonard WJ. Mo F, et al. Among authors: ren m. Nature. 2021 Sep;597(7877):544-548. doi: 10.1038/s41586-021-03861-0. Epub 2021 Sep 15. Nature. 2021. PMID: 34526724
Second-line lenvatinib in patients with recurrent endometrial cancer.
Vergote I, Powell MA, Teneriello MG, Miller DS, Garcia AA, Mikheeva ON, Bidzinski M, Cebotaru CL, Dutcus CE, Ren M, Kadowaki T, Funahashi Y, Penson RT. Vergote I, et al. Among authors: ren m. Gynecol Oncol. 2020 Mar;156(3):575-582. doi: 10.1016/j.ygyno.2019.12.039. Epub 2020 Jan 17. Gynecol Oncol. 2020. PMID: 31955859 Free article. Clinical Trial.
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
Finn RS, Kudo M, Cheng AL, Wyrwicz L, Ngan RKC, Blanc JF, Baron AD, Vogel A, Ikeda M, Piscaglia F, Han KH, Qin S, Minoshima Y, Kanekiyo M, Ren M, Dairiki R, Tamai T, Dutcus CE, Ikezawa H, Funahashi Y, Evans TRJ. Finn RS, et al. Among authors: ren m. Clin Cancer Res. 2021 Sep 1;27(17):4848-4858. doi: 10.1158/1078-0432.CCR-20-4219. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108184 Clinical Trial.
Transcription factor p73 regulates Th1 differentiation.
Ren M, Kazemian M, Zheng M, He J, Li P, Oh J, Liao W, Li J, Rajaseelan J, Kelsall BL, Peltz G, Leonard WJ. Ren M, et al. Nat Commun. 2020 Mar 19;11(1):1475. doi: 10.1038/s41467-020-15172-5. Nat Commun. 2020. PMID: 32193462 Free PMC article.
Tunable Photonic Microspheres of Comb-Like Supramolecules.
Yang Y, Kang TH, Wang K, Ren M, Chen S, Xiong B, Xu J, Zhang L, Yi GR, Zhu J. Yang Y, et al. Among authors: ren m. Small. 2020 Jul;16(29):e2001315. doi: 10.1002/smll.202001315. Epub 2020 Jun 22. Small. 2020. PMID: 32567198
Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma.
Liu J, Yang L, Yuan X, Xiong M, Zhu J, Wu W, Ren M, Long J, Xu X, Gou M. Liu J, et al. Among authors: ren m. Int J Nanomedicine. 2021 Nov 17;16:7697-7709. doi: 10.2147/IJN.S331519. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34819728 Free PMC article.
Moebius strips of chiral block copolymers.
Geng Z, Xiong B, Wang L, Wang K, Ren M, Zhang L, Zhu J, Yang Z. Geng Z, et al. Among authors: ren m. Nat Commun. 2019 Sep 9;10(1):4090. doi: 10.1038/s41467-019-11991-3. Nat Commun. 2019. PMID: 31501424 Free PMC article.
228 results